Zhong Yuan Bio-Technology Holdings Limited
Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived nervonic acid dietary supplements in China. It operates through four segments: Sales of Dietary Supplements; Research and Development Services; Royalties; and Event Organization. It also develops early detection kits for brain diseases and new drugs for neurological diseases; and technical supporting services. It sell… Read more
Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) - Total Liabilities
Latest total liabilities as of September 2024: $3.39 Million USD
Based on the latest financial reports, Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) has total liabilities worth $3.39 Million USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Zhong Yuan Bio-Technology Holdings Limited - Total Liabilities Trend (2017–2025)
This chart illustrates how Zhong Yuan Bio-Technology Holdings Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Zhong Yuan Bio-Technology Holdings Limited Competitors by Total Liabilities
The table below lists competitors of Zhong Yuan Bio-Technology Holdings Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kantone Holdings Limited
PINK:KTHGF
|
USA | $85.46 Million |
|
Excel Force MSC Bhd
KLSE:0065
|
Malaysia | RM16.39 Million |
|
Castelbajac Co. Ltd
KQ:308100
|
Korea | ₩48.08 Billion |
|
Logisys Inc
KQ:067730
|
Korea | ₩9.08 Billion |
|
TMT Investments PLC
LSE:TMT
|
UK | $661.36K |
|
Great Northern Minerals Ltd
AU:GNM
|
Australia | AU$139.85K |
|
Way 2 Vat Ltd
AU:W2V
|
Australia | AU$5.74 Million |
Liability Composition Analysis (2017–2025)
This chart breaks down Zhong Yuan Bio-Technology Holdings Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -16.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhong Yuan Bio-Technology Holdings Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhong Yuan Bio-Technology Holdings Limited (2017–2025)
The table below shows the annual total liabilities of Zhong Yuan Bio-Technology Holdings Limited from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $3.39 Million | 0.00% |
| 2024-03-31 | $3.39 Million | +29.75% |
| 2023-03-31 | $2.61 Million | +36.56% |
| 2022-03-31 | $1.91 Million | -2.33% |
| 2021-03-31 | $1.96 Million | +144.75% |
| 2020-03-31 | $799.65K | +88.75% |
| 2019-03-31 | $423.65K | +1490.21% |
| 2018-03-31 | $26.64K | +3452.13% |
| 2017-03-31 | $750.00 | -- |